Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anas Alawawdeh"'
Autor:
James Moore, Scott Carruthers, Guy J. Maddern, Anas Alawawdeh, Robert Padbury, David Roder, Amitesh Roy, Amanda R. Townsend, Cynthia Piantadosi, Christos S. Karapetis, Timothy J. Price
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 18:428-433
Aim: Reviewing outcomes of regorafenib use in metastatic colorectal cancer using real-world data from the South Australian Metastatic Colorectal Cancer Registry. Methods: A retrospective review of the characteristics and outcomes of patients who rece
Autor:
Anas, Alawawdeh, Cynthia, Piantadosi, Amanda Rose, Townsend, Christos Stelios, Karapetis, Rob, Padbury, Amitesh Chandra, Roy, James, Moore, Guy, Maddern, David, Roder, Annabelle, Smith, Timothy Jay, Price
Publikováno v:
Targeted oncology. 17(1)
Effective targeting of RAS mutations has proven elusive until recently. Novel agents directly targeting KRAS G12C have shown promise in early-phase clinical trials that included patients with metastatic colorectal cancer. Prior reports have suggested
Autor:
Timothy J. Price, Rohit Joshi, Christos S Karapetis, Nimit Singhal, Amitesh Roy, Anas Alawawdeh, Tharani Krishnan
Publikováno v:
Expert review of anticancer therapy. 21(2)
Introduction: A comprehensive trimodality approach has become the standard of care for patients with locally advanced rectal cancer. However, the sequencing and duration of chemotherapy and chemoradiotherapy around surgery varies between clinical stu
Autor:
Dominic Rodrigues, Ian D. Kirkwood, E. A. Wachter, Ruben Sebbon, Susan J. Neuhaus, Anas Alawawdeh, Jessica Reid, Guy J. Maddern, Gabby Cehic, Mark McGregor, Timothy J. Price
Publikováno v:
Journal of Clinical Oncology. 39:4115-4115
4115 Background: Metastatic neuroendocrine neoplasms (mNEN) originating in the gastrointestinal tract are frequently slow growing yet both symptom and disease control remain important. Treatment options include resection, systemic somatostatin analog
Autor:
Gabby Cehic, Rubin Sebbon, Anas Alawawdeh, Guy J. Maddern, Timothy J. Price, Susan J. Neuhaus, Jessic Reid, Lisa Leopardi, E. A. Wachter, Ian Kirkwood
Publikováno v:
Journal of Clinical Oncology. 37:4102-4102
4102 Background: Metastatic neuroendocrine neoplasms (mNEN’s) originating in the gastrointestinal tract are frequently slow growing yet both symptom and disease control remain important. Treatment options include resection, chemoablation, systemic